pubrio
RAPT Therapeutics

RAPT Therapeutics

· Biotechnology

Pharmaceuticals

Biotechnology

Healthcare

RAPT Therapeutics is a clinical-stage biopharmaceutical company dedicated to treating inflammatory and immunologic diseases. Their mission is to develop therapeutics that target key drivers of the immune system, aiming to transform treatments and improve lives. The company's pipeline includes Ozureprubart, a long-acting anti-IgE antibody, which is being evaluated in clinical trials for food allergy.

Company Insights
Company Overview

2019

Founded

Biotechnology

Industry

-

Location

605,534,115

Ranking

0 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding RAPT Therapeutics

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​